Kodiak Sciences INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
T. Rowe Price Associates, Inc. has updated its beneficial ownership filing for Kodiak Sciences Inc., reporting a 5.2% stake as of June 30, 2026.
NASDAQ
Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 5.7% of Kodiak Sciences Inc. common stock.
NASDAQ
Point72 Asset Management and Steven A. Cohen have reported a 1% beneficial ownership stake in Kodiak Sciences Inc. via a Schedule 13G filing.
NASDAQ
Point72 Asset Management, along with affiliates and Steven A. Cohen, has disclosed a 5.5% beneficial ownership stake in Kodiak Sciences Inc.
NASDAQ
SCHEDULE 13G/A: BlackRock Discloses 4.4% Passive Stake in Kodiak Sciences Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.4% passive beneficial ownership stake in Kodiak Sciences Inc. as of March 31, 2025.
NASDAQ
Dr. D. Victor Perlroth has filed an amended Schedule 13G, reporting beneficial ownership of 11.0% of Kodiak Sciences Inc.'s common stock as of December 31, 2024.